Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesIntentional weight loss and risk of lymphohematopoietic cancers
Cancer Causes and Control, 10/27/09
De Roos AJ et al. – It was hypothesized that intentional weight loss may be associated with development of lymphohematopoietic cancers, based on observations of immune suppression following weight loss in short-term studies. Further assessment of intentional weight loss as a possible risk factor for lymphomas may provide insight into the etiology of these cancers.
Methods- At baseline of Women’s Health Initiative Observational Study (1994–1998), participants reported information about intentional weight loss episodes in past 20 years
- Estimated hazard ratios (HRs) and 95% confidence intervals (CIs) among 81,219 women for associations between past intentional weight loss and risk of developing non-Hodgkin lymphoma (NHL), leukemia, and multiple myeloma during an average 9.9 years of follow-up
- Risk of NHL associated with having lost a large maximum amount of weight (≥ 50 pounds, HR = 1.68, 95% CI 1.13–2.50)
- NHL risk also varied by frequency of intentional weight loss; women had increased risk if they lost 50 pounds or more ≥ 3 times or 20–49 pounds ≥ 3 times
- No risk associated with smaller amounts of weight loss (10–19 pounds ≥ 3 times, HR = 0.78, 95% CI 0.46–1.33)
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I Clinical and Pharmacokinetic Study of Oral Sapacitabine in Patients With Acute Leukemia and Myelodysplastic Syndrome
Journal of Clinical Oncology, 12/04/09
Immunoglobulin G Fc Receptor FcgammaRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Journal of Clinical Oncology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor